<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/420FF31C-D0C7-461B-8803-2D64273B3C32"><gtr:id>420FF31C-D0C7-461B-8803-2D64273B3C32</gtr:id><gtr:firstName>Martin</gtr:firstName><gtr:surname>Underwood</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U122785831"><gtr:id>46056AC8-8D7F-4210-B974-AF99AF487996</gtr:id><gtr:title>Are topical or oral Ibuprofen equally effective for the treatment of chronic knee pain in older people? (TOIB)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U122785831</gtr:grantReference><gtr:abstractText>Osteoarthritis is the most common form of arthritis that is encountered in general practice. It is most common in the elderly and causes considerable disability. This study is a preference trial designed to assess the effect of oral compared with the topical application of Ibuprofen for the treatment of osteoarthritis of the knee in people who have suffered with the condition for at least one year. People recruited to the trial will be randomised to either intervention or will be allowed to choose the treatment of their choice. The main outcome of interest is reduction in pain but other outcomes will include satisfaction with the treatment and health service outcomes.</gtr:abstractText><gtr:technicalSummary>Osteoarthritis (OA) is a common condition particularly in older people. Symptoms include chronic pain and reduced mobility. An accurate estimation of the prevalence and health impact of osteoarthritis is difficult, as there is an imprecise relationship between the presence of radiological change and symptoms of pain and/or disability. Data from the Tecumseh study in the USA showed that, based on history, 30% of women and 17% of men aged over 65 had OA and based on examination, 41% for women, and 20% for men had OA. Radiological evidence of OA is nearly universal in older people. Sixty percent of them will have moderate or severe OA in at least one joint. However, only 60% of x-ray changes are associated with symptoms. The population aged over 65 years in the UK is set to increase to one fifth by 2021 and there is evidence to suggest that age corrected consultation rates for osteoarthritis are also rising. Thus managing OA, particularly knee OA, is set to become an even more important health challenge over the coming decades.||The aim of this study is to ascertain in older people with knee pain: if oral and topical Ibuprofen are equally effective at reducing pain and disability; to compare the incidence of possible adverse events from oral and topical Ibuprofen used to treat older people with knee pain; compare the cost of effectiveness and cost utility of oral and topical Ibuprofen used for treatment of older people with knee pain; compare expected and actual satisfaction with treatment with effectiveness of oral and topical Ibuprofen for older people with knee pain; explore how older peoples expressed preferences for and previous use of oral or topical medication for chronic knee pain influences treatment effectiveness and explore older peoples beliefs about and expectations of treatments for chronic knee pain. These will be tested in a randomised controlled trial with a parallel patient preference study. Older people with a history of chronic knee pain and disability that have experienced these symptoms for at least one year will be eligible to take part and will be randomised to receive either oral or topical Ibuprofen from their general practitioners.||This study is funded by the NHS R&amp;amp;D Health Technology Assessment Panel and is a collaboration between GPRF and Queen Marys and Westfield College.</gtr:technicalSummary><gtr:fund><gtr:end>2008-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>137516</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>62CE73BC-1C09-4609-8366-9BAEA85884E0</gtr:id><gtr:title>Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study [ISRCTN: 79353052].</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f77341fd101a21e55aaf15e778c1cf76"><gtr:id>f77341fd101a21e55aaf15e778c1cf76</gtr:id><gtr:otherNames>Castelnuovo E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>56d5624e4a3410.37307154</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5EC576AB-04E9-4D9E-B360-A5402BCC40D6</gtr:id><gtr:title>Advice to use topical or oral ibuprofen for chronic knee pain in older people: randomised controlled trial and patient preference study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590232ca7969db32ac22aa9bdeeea007"><gtr:id>590232ca7969db32ac22aa9bdeeea007</gtr:id><gtr:otherNames>Underwood M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_16519_19_18056743</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86E87BED-7E88-40A5-A6FA-1669F3B251FE</gtr:id><gtr:title>Influences on older people's decision making regarding choice of topical or oral NSAIDs for knee pain: qualitative study.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e68384cef67a02f38ca851f0d546722e"><gtr:id>e68384cef67a02f38ca851f0d546722e</gtr:id><gtr:otherNames>Carnes D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn><gtr:outcomeId>pm_16519_19_18056742</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15B78800-EB6E-437B-9683-1877BE2D363F</gtr:id><gtr:title>Topical or oral ibuprofen for chronic knee pain in older people. The TOIB study.</gtr:title><gtr:parentPublicationTitle>Health technology assessment (Winchester, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/590232ca7969db32ac22aa9bdeeea007"><gtr:id>590232ca7969db32ac22aa9bdeeea007</gtr:id><gtr:otherNames>Underwood M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1366-5278</gtr:issn><gtr:outcomeId>pm_16519_19_18505668</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_U122785831</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>149FA87E-B8CD-4FFC-B515-EAD312BED03B</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Musculoskeletal</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>